CODY MYGRANT: Open Payments
NPI 1528435153 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,546 in 49 payments from 9 companies in 2025. Trend: 2023 $1,023 · 2024 $1,252 · 2025 $1,546
Food & beverage: $1,546
| Company | Payments | Amount |
|---|---|---|
| Ethicon US, LLC | 14 | $504 |
| Lilly USA, LLC | 12 | $236 |
| Novo Nordisk Inc | 9 | $224 |
| AstraZeneca Pharmaceuticals LP | 4 | $188 |
| ABBVIE INC. | 3 | $130 |
| Smith+Nephew, Inc. | 3 | $117 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $90 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
Products named: STRATAFIX, MOUNJARO, FARXIGA, Ozempic, VISTASEAL, ZEPBOUND, Harmonic, QULIPTA.
Industry payments across TX — which companies pay providers there.
